Protective Effect Against Acute Experimental Toxoplasmosis Conferred by Intranasal Immunisation with <i>Toxoplasma gondii</i> Membrane Proteins Plus CpG Adjuvant.

Vaccines (Basel) · 2026 · PMC13308317 · PMID 42347660

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A tendency toward reduced parasitic load was observed in the liver, kidney, heart, and brain, although it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Protective Effect Against Acute Experimental Toxoplasmosis Conferred by Intranasal Immunisation with &lt;i&gt;Toxoplasma gondii&lt;/i&gt; Membrane Proteins Plus CpG Adjuvant.

The sentences

Protective Effect Against Acute Experimental Toxoplasmosis Conferred by Intranasal Immunisation with <i>Toxoplasma gondii</i> Membrane Proteins Plus CpG Adjuvant.